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Abstract
Commensal gut bacteria are necessary for the complete development of mucosal innate and adaptive
immunity and thus may influence intestinal and systemic immune disorders. Recent work has
advanced our understanding of this association by identification of a single taxon of the murine
microbiota which can stimulate T-cell development and differentiation. It is hoped that further
characterization of the mechanisms involved will enable targeted manipulation of the microbiota-
immune system relationship.
Introduction and context
Eukaryotes have been living in intimate contact with
prokaryotes throughout the course of evolution. Espe-
cially in the context of the gut, the host has developed
highly conserved interrelated systems to protect itself
from pathogenic attack whilst allowing beneficial
microbes – symbionts – to thrive. Past study of
primordial immune mechanisms conserved in non-
vertebrates has richly informed our understanding of
the activation (and suppression) of innate immune
networks. As adaptive immunity is restricted to verte-
brates, our appreciation of how gut commensal com-
munities interact with mucosal and systemic adaptive
immunity is less understood.
The gut/mucosal arm of the adaptive immune system
provides humoral and cell-mediated immunity against
ingested antigens and luminal organisms and is localized
predominantly in the small bowel. Effector lymphocytes
are diffusely distributed in the lamina propria (LP) or in
isolated lymphoid follicles or are organized into discrete
structures termed Peyer’s patches, which are essentially
mucosal lymph nodes overlaid with a specialized
epithelial cell type, the M cell, which possesses the
endocytic machinery for uptake of particulate antigens
from the gut lumen. Members of the normal flora, along
with non-viable particulate antigens and all-too-viable
pathogens, are continually being sampled by the M cells
and perhaps other portals for processing by local
dendritic cells or macrophages and subsequent educa-
tion and activation of effector B and T cells [1].
The microbiota is clearly involved in the anatomic and
functional development of mucosal immunity [2].
Peyer’s patches are grossly hypoplastic and IgA responses
are reduced in germ-free animals. It is also known that
germ-free animals have reduced total CD4 T-cell
populations and an inappropriate balance of TH-cell
subsets [3], which can be moderated within weeks upon
colonization with a representative member of the
normal flora (Bacteroides fragilis) [4] via dendritic cell
recognition of a specific polysaccharide (polysaccharide
A) component of B. fragilis [5]. Interestingly, the
intestinal LP in healthy animals was shown to be a
major location of a unique population of interleukin-
17-producing CD4
+ T cells (TH17 cells) distinct from
TH1- or TH2-cell lineages [6,7]. This work has spawned an
explosion of interest in the development and functions
of TH17 cells in health and disease, especially in the
gastrointestinal tract. While TH17 cells are increased in
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these cells are pathogenic or protective during intestinal
inflammation; additionally, the mechanisms driving
their development and differentiation are now only
beginning to emerge [8].
Major recent advances
Analyses in germ-free mice as well as antibiotic-treated
conventional mice have shown that the intestinal
microbiota can drive the development of TH17 cells in
the murine intestine [9,10]. The mechanism by which
the intestinal microbiota induces TH17 cells is not via the
classical Toll-like receptor adaptor molecules MyD88
or Trif, but potentially via ATP generation. To begin to
probe which components of the diverse microbiota
may preferentially induce TH17 cells, Ivanov et al. [11]
performed an immunophenotypic comparison of the
same mouse strain (B6) obtained from two commercial
vendors (Taconic, Tarrytown, NY, USA, and The Jackson
Laboratory, Bar Harbor, ME, USA) and found that the
mice from The Jackson Laboratory showed a remarkable
lack of TH17 cells in the LP. Interestingly, transfer of
Taconic flora (by direct gavage of fecal flora or by
cohousing) to the mice from The Jackson Laboratory
resulted in the induction of LP TH17 cells, indicating a
stark difference in the immunostimulatory potential of
the distinct microbiota. This observation has been
further developed in two recent papers by Ivanov et al.
[11] and Gaboriau-Routhiau et al. [12], both reaching
the surprising conclusion that T-cell development in
general and TH17 differentiation in particular are largely
induced by the action of a single (or at least limited)
number of bacterial taxa.
In the paper of Ivanov and colleagues [11], the authors
exploited the Phylochip (Affymetrix, Santa Clara, CA,
USA) – a 16s ribosomal microarray platform that serves
as a massive (300,000 probe) parallel survey of micro-
bial taxa – and identified segmented filamentous
bacteria (SFB), a non-culturable spore-forming Gram-
positive Clostridia-related species present in B6 mice
from Taconic, but not The Jackson Laboratory. With the
use of germ-free mice or Jackson Laboratory-sourced
mice colonized (‘conventionalized’) with SFB, this group
studied TH17 differentiation in LP lymphocyte popula-
tions and expression profiling to show that SFB could
recapitulate the inductive effects of the intact Taconic
microbiota [11]. An independent group headed by
Gaboriau-Routhiau also used an expression profiling
approach to characterize host responses of germ-free
mice conventionalized with normal murine microbiota
and found distinct patterns of innate (inflammatory)
gene expression and adaptive immune stimulation
(LP T-cell maturation). This signature of normal immune
development was not induced by candidate mono-
associated microbiota representatives or complex nor-
mal human microflora [12]; however, the host immune
response pattern to normal murine microflora could be
recapitulated by SFB as a mono-associated strain, further
implicating this taxon as a primary driver of adaptive
immune development (Figure 1).
Future directions
Though intriguing, these findings raise many important
questions. SFB are not cultivable and must be main-
tained in monocultured mice [13] and introduced to
other mice by cohousing. Thus, further characterization
of the SFB is obviously necessary; sequencing of their
genome will be eagerly anticipated, as will be culture
techniques that may allow them to be more readily
introduced into test systems. It will be interesting to see
what other taxa can mediate the immune stimulatory
phenotype and whether there is a specific ligand
(microbial-associated molecular pattern, or MAMP)
present on a subset (perhaps a very limited subset) of
commensals. Conversely, what are the specific receptors
that the host uses to perceive this functional class of
Figure 1. Intestinal microflora modulates mucosal immune
responses
Recent reports implicate segmented filamentous bacteria (SFB) as the major
component of the commensal microbiota which modulates mucosal T-cell
development/responses. SFB, in particular, are potent inducers of TH17
differentiation. The mechanisms by which these bacteria direct T-cell
differentiation are poorly understood at present but may include direct
interactions with intestinal epithelial cells, dendritic cells (DC), or
macrophages (Mφ) (or all three). Treg, regulatory T cells.
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intestine sense SFB in order to direct adaptive immunity?
In directing TH-cell differentiation, do SFB and other
commensal bacteria directly interact with LP dendritic
cells and macrophages that augment TH17 and Treg
(regulatory T) responses [14-17] or do they induce
changes in intestinal epithelial cells that in turn imprint
dendritic cells with this capacity [18]? Are SFB invasive to
epithelial cells? It is also clearly important to identify the
human SFB equivalent(s). As potential targets for
modification, SFB may offer a clue to the identification
of bacteria that could be added to (or suppressed from)
the microflora to accrue benefits such as altered immune
regulation relevant to human disorders such as inflam-
matory bowel disease and systemic autoimmunity.
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